Polarization of Tumor Cells and Tumor‐Associated Macrophages: Molecular Mechanisms and Therapeutic Targets
MedComm · 2025-09 · 6 (9)
DOI: 10.1002/mco2.70372 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, 2025-09. Verfasst von Guohao Wei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology The Second Hospital of Nanjing Nanjing University of Chinese Medicine Nanjing China. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 207 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Tumor‐associated macrophages (TAMs) are prominent constituents of solid tumors, and their prevalence is often associated with poor clinical outcomes. These highly adaptable immune cells undergo dynamic functional changes within the immunosuppressive tumor microenvironment (TME), engaging in reciprocal interactions with malignant cells. This bidirectional communication facilitates concurrent phenotypic transformation: tumor cells shift toward invasive mesenchymal states, whereas TAMs develop immunosuppressive, pro‐tumorigenic traits. Increasing evidence highlights metabolic reprogramming, characterized by dysregulation of lipid metabolism, amino acid utilization, and glycolytic activity, as the fundamental molecular basis orchestrating this pathological symbiosis. However, a comprehensive understanding of how metabolic reprogramming specifically coordinates the mutual polarization of tumor cells and TAMs is lacking. This review thoroughly examines the molecular mechanisms governing this co‐polarization process, detailing critical transcriptional regulators, essential signaling pathways, and the maintenance of adaptive phenotypes within the TME. Furthermore, this review critically assesses promising therapeutic strategies aimed at disrupting this alliance, including the use of metabolically targeted agents, engineered chimeric antigen receptor macrophages, and TAM‐selective nanoparticle delivery systems. These insights provide a crucial foundation for the development of next‐generation cancer immunotherapies focused on reprogramming pathological polarization dynamics to overcome treatment resistance and improve clinical outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology The Second Hospital of Nanjing Nanjing University of Chinese Medicine Nanjing China.
- The Comprehensive Cancer Center, Department of Central Laboratory, The Affiliated Huai'an No.1 People's Hospital Nanjing Medical University Huai'an China.
- Department of Biochemistry and Molecular Biology, School of Medicine, Nanjing University of Chinese Medicine, No.138 Xianlin Avenue Nanjing University of Chinese Medicine Nanjing China.
- Jiangsu Province Engineering Research Center of Traditional Chinese Medicine Health Preservation Nanjing University of Chinese Medicine Nanjing China.
ORCID-Profile: Lilin Ge
Förderung
- China Postdoctoral Science Foundation
Zitieren
APA
Wei, G., Li, B., Huang, M., Lv, M., Liang, Z., Zhu, C., Ge, L., & Chen, J. (2025). Polarization of Tumor Cells and Tumor‐Associated Macrophages: Molecular Mechanisms and Therapeutic Targets. MedComm, 6(9). https://doi.org/10.1002/mco2.70372
Vancouver
Wei G, Li B, Huang M, Lv M, Liang Z, Zhu C, et al. Polarization of Tumor Cells and Tumor‐Associated Macrophages: Molecular Mechanisms and Therapeutic Targets. MedComm. 2025;6(9). doi:10.1002/mco2.70372
BibTeX
@article{Wei2025,
author = {Wei, Guohao and Li, Bin and Huang, Mengyang and Lv, Mengyao and Liang, Zihui and Zhu, Chuandong and Ge, Lilin and Chen, Jing},
title = {Polarization of Tumor Cells and Tumor‐Associated Macrophages: Molecular Mechanisms and Therapeutic Targets},
journal = {MedComm},
year = {2025},
volume = {6},
number = {9},
doi = {10.1002/mco2.70372}
}
EUVIMED